These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10078547)
1. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Roep BO; Stobbe I; Duinkerken G; van Rood JJ; Lernmark A; Keymeulen B; Pipeleers D; Claas FH; de Vries RR Diabetes; 1999 Mar; 48(3):484-90. PubMed ID: 10078547 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242 [TBL] [Abstract][Full Text] [Related]
3. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445 [TBL] [Abstract][Full Text] [Related]
4. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350 [TBL] [Abstract][Full Text] [Related]
5. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046 [TBL] [Abstract][Full Text] [Related]
6. Sensitization to HLA antigens in islet recipients with failing transplants. Olack BJ; Swanson CJ; Flavin KS; Phelan D; Brennan DC; White NH; Lacy PE; Scharp DW; Poindexter N; Mohanakumar T Transplant Proc; 1997 Jun; 29(4):2268-9. PubMed ID: 9193621 [No Abstract] [Full Text] [Related]
7. Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient. van der Torren CR; Suwandi JS; Lee D; Van't Wout ET; Duinkerken G; Swings G; Mulder A; Claas FH; Ling Z; Gillard P; Keymeulen B; In't Veld P; Roep BO Cell Transplant; 2017 Jan; 26(1):1-9. PubMed ID: 27729094 [TBL] [Abstract][Full Text] [Related]
8. Monitoring human islet allografts using a forearm biopsy site. Stegall MD Ann Transplant; 1997; 2(3):8-11. PubMed ID: 9869858 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes. Vantyghem MC; Fajardy I; Pigny P; Noel C; Kerr-Conte J; Gmyr V; Vandewalle B; Proye C; Pattou F Diabetes Metab; 2003 Dec; 29(6):595-601. PubMed ID: 14707888 [TBL] [Abstract][Full Text] [Related]
10. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases. Socci C; Falqui L; Davalli AM; Ricordi C; Braghi S; Bertuzzi F; Maffi P; Secchi A; Gavazzi F; Freschi M Acta Diabetol; 1991; 28(2):151-7. PubMed ID: 1777651 [TBL] [Abstract][Full Text] [Related]
11. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. Huurman VA; Hilbrands R; Pinkse GG; Gillard P; Duinkerken G; van de Linde P; van der Meer-Prins PM; Versteeg-van der Voort Maarschalk MF; Verbeeck K; Alizadeh BZ; Mathieu C; Gorus FK; Roelen DL; Claas FH; Keymeulen B; Pipeleers DG; Roep BO PLoS One; 2008 Jun; 3(6):e2435. PubMed ID: 18560516 [TBL] [Abstract][Full Text] [Related]
12. Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects. Huurman VA; van der Torren CR; Gillard P; Hilbrands R; van der Meer-Prins EP; Duinkerken G; Gorus FK; Claas FH; Keymeulen B; Roelen DL; Pipeleers DG; Roep BO Clin Exp Immunol; 2012 Aug; 169(2):190-8. PubMed ID: 22774994 [TBL] [Abstract][Full Text] [Related]
13. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Hilbrands R; Huurman VA; Gillard P; Velthuis JH; De Waele M; Mathieu C; Kaufman L; Pipeleers-Marichal M; Ling Z; Movahedi B; Jacobs-Tulleneers-Thevissen D; Monbaliu D; Ysebaert D; Gorus FK; Roep BO; Pipeleers DG; Keymeulen B Diabetes; 2009 Oct; 58(10):2267-76. PubMed ID: 19602536 [TBL] [Abstract][Full Text] [Related]
14. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
15. Effect of pancreatic islet allografts on kidney allograft rejection incidence in simultaneous islet/kidney and islet after kidney recipients. Wahoff DC; Najarian JS; Sutherland DE; Gores PF Transplant Proc; 1994 Apr; 26(2):576. PubMed ID: 8171562 [No Abstract] [Full Text] [Related]
16. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]